Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies
Gagan K. Gupta, Amber L. Collier, Dasom Lee, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2392-2392
Open Access | Times Cited: 243

Showing 1-25 of 243 citing articles:

Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
Onyinyechi Obidiro, Gantumur Battogtokh, Emmanuel O. Akala
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1796-1796
Open Access | Times Cited: 136
Tumor Microenvironment in Breast Cancer—Updates on Therapeutic Implications and Pathologic Assessment
Joshua Li, Julia Y. Tsang, Gary M. Tse
Cancers (2021) Vol. 13, Iss. 16, pp. 4233-4233
Open Access | Times Cited: 125
Triple-negative breast cancer metastasis involves complex epithelial-mesenchymal transition dynamics and requires vimentin
Eloïse M. Grasset, Matthew Dunworth, Gaurav Sharma, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 656
Open Access | Times Cited: 106
Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer
Shengnan Sha, Luyi Si, Xinrui Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 101
Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type
Md Abdus Subhan, Farzana Parveen, Hassan Shah, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2204-2204
Open Access | Times Cited: 51
A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy
Yuan Chen, Zhuo Yao, Peilian Liu, et al.
Acta Biomaterialia (2023) Vol. 159, pp. 275-288
Closed Access | Times Cited: 46
Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer
Xinyun Qiu, Yan Qu, Beibei Guo, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 498-510
Closed Access | Times Cited: 80
Triple Negative Breast Cancer: A Mountain Yet to Be Scaled Despite the Triumphs
Qitong Wu, Sumit Siddharth, Dipali Sharma
Cancers (2021) Vol. 13, Iss. 15, pp. 3697-3697
Open Access | Times Cited: 67
Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
Onyinyechi Obidiro, Gantumur Battogtokh, Emmanuel O. Akala
(2023)
Open Access | Times Cited: 37
Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways
Nisa Chuangchot, Pranisa Jamjuntra, Supaporn Yangngam, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 28
Challenges and Opportunities in Developing Targeted Therapies for Triple Negative Breast Cancer
Abygail G. Chapdelaine, Gongqin Sun
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1207-1207
Open Access | Times Cited: 23
Small molecule agents for triple negative breast cancer: Current status and future prospects
Yan Ou, Mengchao Wang, Qian Xu, et al.
Translational Oncology (2024) Vol. 41, pp. 101893-101893
Open Access | Times Cited: 13
Triple-Negative Breast Cancer and Emerging Therapeutic Strategies: ATR and CHK1/2 as Promising Targets
Amalia A. Sofianidi, Ecaterina E. Dumbrava, Konstantinos N. Syrigos, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1139-1139
Open Access | Times Cited: 9
SBFI26 induces triple‐negative breast cancer cells ferroptosis via lipid peroxidation
Gang He, Yiyuan Zhang, Yanjiao Feng, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 7
Open Access | Times Cited: 9
Electroacupuncture normalized tumor vasculature by downregulating glyoxalase-1 to polarize tumor-associated macrophage to M1 phenotype in triple-negative breast cancer
Xuewei Qi, Yanyan Lian, Zhenjia Fan, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113988-113988
Closed Access | Times Cited: 1
The prognostic value of changes in Ki67 following neoadjuvant chemotherapy in residual triple-negative breast cancer: a Swedish nationwide registry-based study
Jenny Nyqvist, Mostafa Helou, Khalil Helou, et al.
Breast Cancer Research and Treatment (2025)
Open Access | Times Cited: 1
DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities
Wenyu Cai, Xiaoli Cai, Yi-ran Fei, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 1
All-trans retinoic acid enhances anti-proliferative effect of dual PI3K and mTOR inhibitor NVP-BEZ235 in triple negative breast cancer
Suranur Ayvaz, Zeynep Büşra Bolat
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access | Times Cited: 1
High G2M Pathway Score Pancreatic Cancer is Associated with Worse Survival, Particularly after Margin-Positive (R1 or R2) Resection
Masanori Oshi, Stephanie Newman, Yoshihisa Tokumaru, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2871-2871
Open Access | Times Cited: 54
Precise Regulation of Enzyme–Nanozyme Cascade Reaction Kinetics by Magnetic Actuation toward Efficient Tumor Therapy
Ye Zhang, Yanyun Wang, Qi Zhou, et al.
ACS Applied Materials & Interfaces (2021) Vol. 13, Iss. 44, pp. 52395-52405
Closed Access | Times Cited: 44
Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression
Damiano Cosimo Rigiracciolo, Francesca Cirillo, Marianna Talia, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 645-645
Open Access | Times Cited: 43
TH1902, a new docetaxel‐peptide conjugate for the treatment of sortilin‐positive triple‐negative breast cancer
Michel Demeule, Cyndia Charfi, Jean‐Christophe Currie, et al.
Cancer Science (2021) Vol. 112, Iss. 10, pp. 4317-4334
Open Access | Times Cited: 43
Extracellular Vesicles From the Human Natural Killer Cell Line NK3.3 Have Broad and Potent Anti-Tumor Activity
Allyson M. Cochran, Jacki Kornbluth
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 41
ROCK1 mechano-signaling dependency of human malignancies driven by TEAD/YAP activation
Davide Esposito, Ila Pant, Yao Shen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 37
EIF4A3-mediated circPRKCI expression promotes triple-negative breast cancer progression by regulating WBP2 and PI3K/AKT signaling pathway
Xuehui Wang, Hongming Song, Lin Fang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top